These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20550842)

  • 1. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.
    Li J; Hall IJ; Zhao G
    Cancer Causes Control; 2017 Mar; 28(3):235-240. PubMed ID: 28210882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance System.
    Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Peipins LA; Smith JL
    J Am Board Fam Med; 2021; 34(3):634-647. PubMed ID: 34088823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of prostate cancer screening using Andersen's Behavioral Model of Health Services Use.
    Ogunsanya ME; Jiang S; Thach AV; Bamgbade BA; Brown CM
    Urol Oncol; 2016 Dec; 34(12):529.e9-529.e14. PubMed ID: 27450892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.
    Beaulac JA; Fry RN; Onysko J
    Can J Public Health; 2006; 97(3):171-6. PubMed ID: 16827400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.
    Scosyrev E; Wu G; Golijanin D; Messing E
    BJU Int; 2012 Nov; 110(10):1485-90. PubMed ID: 22448649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
    Ross LE; Taylor YJ; Richardson LC; Howard DL
    J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared decision making in prostate-specific antigen testing with men older than 70 years.
    Li J; Berkowitz Z; Richards TB; Richardson LC
    J Am Board Fam Med; 2013; 26(4):401-8. PubMed ID: 23833155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.
    Frendl DM; Epstein MM; Fouayzi H; Krajenta R; Rybicki BA; Sokoloff MH
    Cancer Causes Control; 2020 Sep; 31(9):861-867. PubMed ID: 32556947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital.
    Dean LT; Subramanian SV; Williams DR; Armstrong K; Zubrinsky Charles C; Kawachi I
    Am J Mens Health; 2015 Sep; 9(5):385-96. PubMed ID: 25117538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of follow-up of prostate-specific antigen test results.
    McFall SL; Smith DW
    Public Health Rep; 2009; 124(5):718-25. PubMed ID: 19753950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States Preventive Services Task Force recommendations against it: a retrospective cohort study.
    Goodwin JS; Jaramillo E; Yang L; Kuo YF; Tan A
    PLoS One; 2014; 9(9):e107352. PubMed ID: 25208250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
    Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
    JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.